Zobrazeno 1 - 10
of 812
pro vyhledávání: '"S Mackinnon"'
Autor:
Erin S. Mackinnon, Lawrence A. Leiter, Rajvi J. Wani, Natasha Burke, Eileen Shaw, Kelcie Witges, Shaun G. Goodman
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 1, Pp 205-220 (2024)
Abstract Introduction The 2021 Canadian Cardiovascular Society (CCS) guidelines recommend intensive low-density lipoprotein cholesterol (LDL-C) reduction for patients with atherosclerotic cardiovascular disease (ASCVD). For patients above LDL-C thres
Externí odkaz:
https://doaj.org/article/f410e393493f41d99f475ee20cef9c48
Autor:
Lawrence A. Leiter, Robert A. Hegele, Vivien Brown, Jean Bergeron, Erin S. Mackinnon, G. B. John Mancini
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 10, p 383 (2024)
Externí odkaz:
https://doaj.org/article/571d110f310246ae8c213f2595e67747
Autor:
Milan Gupta, Rajvi J. Wani, Khalid Al Faraidy, Jean Bergeron, Eduardo Contreras, Angel Alberto Garcia Peña, G. B. John Mancini, Francisco Padilla, Abel Alberto Pavia Lopez, Kiran Philip, Johnny Wu, Erin S. Mackinnon
Publikováno v:
Cardiology and Therapy, Vol 12, Iss 4, Pp 703-722 (2023)
Abstract Introduction This study characterizes patients receiving evolocumab in clinical practice and assesses treatment effectiveness, safety and persistence outcomes across five countries. Methods This retrospective and prospective observational st
Externí odkaz:
https://doaj.org/article/871e335605904a328cdc04840034dac7
Autor:
Lawrence A. Leiter, Robert A. Hegele, Vivien Brown, Jean Bergeron, Erin S. Mackinnon, G. B. John Mancini
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 25, Iss 5, p 190 (2024)
Elevated low-density lipoprotein cholesterol (LDL-C) is a major causal factor for atherosclerotic cardiovascular disease (ASCVD), the leading cause of mortality worldwide. Statins are the recommended first-line lipid-lowering therapy (LLT) for patien
Externí odkaz:
https://doaj.org/article/7d37757b25cc40d5b67d09e98b0d1b2e
Autor:
Erin S. Mackinnon, Bryan Har, Salimah Champsi, Rajvi J. Wani, Lee Geyer, Eileen Shaw, Megan S. Farris, Todd J. Anderson
Publikováno v:
Cardiology and Therapy, Vol 12, Iss 2, Pp 327-338 (2023)
Abstract Introduction A high proportion of Canadian patients with acute myocardial infarction (AMI) do not achieve the threshold low-density lipoprotein cholesterol (LDL-C) levels recommended by the Canadian Cardiovascular Society in 2021. This incre
Externí odkaz:
https://doaj.org/article/bca551537f584890ab3ee4e2afa9336b
Autor:
Said Mekari, René J. L. Murphy, Andrew R. S. MacKinnon, Quinn Hollohan, Samantha C. Macdougall, Molly K. Courish, Derek S. Kimmerly, Heather F. Neyedli
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Microgravity has been shown to be a significant stressor on the cardiovascular system and the brain due to the redistribution of fluids that occurs in the absence of gravitational force, but there is scarce literature surrounding the effects
Externí odkaz:
https://doaj.org/article/a06beaf3e7904cf48847115a44316c1d
Autor:
Milan Gupta, MD, G.B. John Mancini, MD, Rajvi J. Wani, PhD, Vineeta Ahooja, MD, Jean Bergeron, MD, MSc, Priya Manjoo, MD, A. Shekhar Pandey, MD, Maureen Reiner, MS, MA, Johnny Beltran, MD, MSc, Thiago Oliveira, MD, Erin S. Mackinnon, PhD
Publikováno v:
CJC Open, Vol 4, Iss 6, Pp 558-567 (2022)
Background: The 2021 Canadian Cardiovascular Society guidelines recommend proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitor therapy in patients with atherosclerotic cardiovascular disease whose low-density lipoprotein cholesterol (LDL-C
Externí odkaz:
https://doaj.org/article/df511878ce8c449793c63df404c3667b
Autor:
Erin S. Mackinnon, PhD, Ron Goeree, BA, MA, Shaun G. Goodman, MD, MSc, Raina M. Rogoza, MSc, Millicent Packalen, BSc(Hons), Louisa Pericleous, PhD, Ponda Motsepe-Ditshego, MD, Paul Oh, MD, MSc, FRCPC
Publikováno v:
CJC Open, Vol 4, Iss 2, Pp 206-213 (2022)
Background: Cardiovascular disease is the second-leading cause of death in Canada. However, limited data are available on the prevalence of atherosclerotic cardiovascular disease (ASCVD) in Canada. The study objective was to describe the incidence an
Externí odkaz:
https://doaj.org/article/21c9744ceb2b4bf7a20b814617ce7712
Autor:
Michael G. Sugiyama, Haotian Cui, Dar’ya S. Redka, Mehran Karimzadeh, Edurne Rujas, Hassaan Maan, Sikander Hayat, Kyle Cheung, Rahul Misra, Joseph B. McPhee, Russell D. Viirre, Andrew Haller, Roberto J. Botelho, Raffi Karshafian, Sarah A. Sabatinos, Gregory D. Fairn, Seyed Ali Madani Tonekaboni, Andreas Windemuth, Jean-Philippe Julien, Vijay Shahani, Stephen S. MacKinnon, Bo Wang, Costin N. Antonescu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-18 (2021)
Abstract The COVID-19 pandemic has highlighted the urgent need for the identification of new antiviral drug therapies for a variety of diseases. COVID-19 is caused by infection with the human coronavirus SARS-CoV-2, while other related human coronavi
Externí odkaz:
https://doaj.org/article/6fc7b459daf94a499be2325b0bbff79f
Autor:
Erin S. Mackinnon, Bryan Har, Salimah Champsi, Rajvi J. Wani, Lee Geyer, Eileen Shaw, Megan S. Farris, Todd J. Anderson
Publikováno v:
Cardiology and Therapy, Vol 12, Iss 2, Pp 339-339 (2023)
Externí odkaz:
https://doaj.org/article/209ae1db139f4699ba8842fffb84ac14